RELATED CONTENT
NEWS
- Biogen seeks to retain lead in MS market with US BG-12 submission
- Novartis's misfortunes with Gilenya could provide a boost for other MS drug makers
- Latecomer Merck Serono submits Rebif in Europe for early signs of MS
- Merck Serono ditches cladribine, leaving MS franchise exposed
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

